[Randiomized trial of a new platelet anti-aggregant agent: ticlopidine].
D000328:Adult; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010919:Placebos; D010974:Platelet Aggregation / Q000187:drug effects
D005343:Fibrinolytic Agents; D010919:Placebos
Essai radomisé d'un nouvel agent anti-agrégant : la ticlopidine.